Orexin

A road that reads road to recovery

Biotech

C4X sells substance disorder drug rights to Indivior for $20M

Indivior has paid C4X Discovery 15.95 million pounds sterling ($20.4 million) to gain full rights to an orexin-1 receptor antagonist.

James Waldron Aug 1, 2023 7:49am

Malcolm Weir - Sosei Heptares

Sosei spins out 2 CNS companies with help from Medicxi

Feb 4, 2019 10:23am

Clive Dix - C4X Discovery CEO

U.K.'s C4XD leaps on $294M addiction deal with Indivior

Mar 29, 2018 9:26am